Immunomodulation of musk-moxa-string therapy in patients with scrofula
Shen Guan-xin , Su Na , Zhu Hui-fen , Wang Xiao-lin , Zhang Yue , Sun Bei , Hong Shu-yun , Liu Guang-yuan
Current Medical Science ›› 1990, Vol. 10 ›› Issue (3) : 164 -168.
Immunomodulation of musk-moxa-string therapy in patients with scrofula
The effects of musk-moxa-string therapy on the immune system in man were investigated in 39 patients with scrofula. Before treatment, the numbers of peripheral blood (PB) CD3+ and DC4+ cells and the ratio CD4+/ CD8+ were found to be lower in patients with scrofula than in normal subjects, while those of B cells and DR+ cells were higher. Response of peripheral blood mononuclear cells (PBMC) to phytohemagglutinin (PHA) diminished in patients with scrofula. At month 2–6 of musk-moxa-string therapy the number of PB CD8+ cells showed slight diminution along with significant increaes in CD3+ and CD4+ cells and CD4+/CD8+ ratio in total lymphocytes (P<0.001). In vitro a marked increased blastogenic response to mitogen stimulation with PHA was observed in PBMC of patients with scrofula after treatment (P<0.001). In contrast, B lymphocytes, monocytes, DR+ cells and blastogenic response to concanavalin A and pokeweed mitogen were not influenced by musk-moxa-string therapy.
scrofula / musk-moxa-string therapy / lymphocyte subsets / blastogenic response / immunomodulation
| [1] |
|
| [2] |
1990;28: 150–2. |
| [3] |
|
| [4] |
|
| [5] |
|
| [6] |
1987;10 (4):211. |
/
| 〈 |
|
〉 |